logo
Researchers turn toxic fungus into potent anti-cancer compound

Researchers turn toxic fungus into potent anti-cancer compound

Hans India3 days ago

A team of US researchers has turned a deadly fungus into a potent cancer-fighting compound, according to a new study.
The result was a promising cancer-killing compound that rivals FDA-approved drugs and opens up new frontiers in the discovery of more fungal medicines, according to the study by University of Pennsylvania's School of Engineering and Applied Science.
'Fungi gave us penicillin. These results show that many more medicines derived from natural products remain to be found,' said Sherry Gao, Presidential Penn Compact Associate Professor in Chemical and Biomolecular Engineering (CBE) and senior author of a new paper in Nature Chemical Biology journal.
The therapy in question is a class of ribosomally synthesized and post-translationally modified peptides, or RiPPs, pronounced like the 'rip' in a piece of fabric.
The name refers to how the compound is produced — by the ribosome, a tiny cellular structure that makes proteins — and the fact that it is modified later, in this case, to enhance its cancer-killing properties.
'Purifying these chemicals is difficult,' says Qiuyue Nie, a postdoctoral fellow in CBE and the paper's first author. While thousands of RiPPs have been identified in bacteria, only a handful have been found in fungi. In part, this is because past researchers misidentified fungal RiPPs as non-ribosomal peptides and had little understanding of how fungi created the molecules.
'The synthesis of these compounds is complicated,' adds Nie. 'But that's also what gives them this remarkable bioactivity.'
To find more fungal RiPPs, the researchers first scanned a dozen strains of Aspergillus, which previous research suggested might contain more of the chemicals.
By comparing chemicals produced by these strains with known RiPP building blocks, the researchers identified A. flavus as a promising candidate for further study.
Genetic analysis pointed to a particular protein in A. flavus as a source of fungal RiPPs. When the researchers turned the genes that create that protein off, the chemical markers indicating the presence of RiPPs also disappeared.
This novel approach — combining metabolic and genetic information — not only pinpointed the source of fungal RiPPs in A. flavus, but could be used to find more fungal RiPPs in the future.
Notably, the compounds had little to no effect on breast, liver or lung cancer cells — or a range of bacteria and fungi — suggesting that asperigimycins' disruptive effects are specific to certain types of cells, a critical feature for any future medication.
The next step is to test asperigimycins in animal models, with the hope of one day moving to human clinical trials.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hair loss isn't just a man's problem. Four ways to treat female baldness.
Hair loss isn't just a man's problem. Four ways to treat female baldness.

Mint

time5 hours ago

  • Mint

Hair loss isn't just a man's problem. Four ways to treat female baldness.

As a professional dancer on Broadway, Lindsey Cornman was known for her curly, strawberry-blonde hair along with her high kicks and pirouettes. When balls of her hair started falling in the shower, it eroded her self-confidence. She ended up getting divorced, though hair loss wasn't the primary reason. 'It didn't help to not feel good about myself," says Cornman, now 42 years old. Fifty-five percent of women deal with hair loss by the age of 70, dermatologists at Rutgers New Jersey Medical School and Marconi University found. The most common condition is female-pattern hair loss, which is genetic, affecting 30 million women in the U.S. By comparison, more than 80% of men experience hair loss and 50 million men have male-pattern hair loss, found NYU Langone Health and the National Institutes of Health, respectively. 'I see more women with concerns about hair loss than men," says Dr. Christina Weng, dermatologist at Massachusetts General Hospital and chief medical officer at Pelage Pharmaceuticals. She says treatment options can be divided into four categories: medicine, therapy, nutritional supplements, and lifestyle changes. 'The best treatment is the one they are going to stick with, because they aren't overnight fixes, and they won't see results for at least six months." What does the female-pattern hair loss look like? It usually shows up as the widening of the part line at the top of the head, and thinning all over the scalp, explains Dr. Weng. The silver lining: The hair line at the front of the scalp usually stays the same for women, contrary to men with receding hair lines. Here are the treatment options: Medicine The most commonly prescribed drug is Minoxidil, the only FDA-approved treatment for hair loss. Dr. Weng says it works better for people who can convert an enzyme in the hair follicle to its active form—overall, only 30% of people respond to it. Another medicine is Spironolactone, which helps block the testosterone derivate DHT that contributes to genetic hair loss. It is especially effective if women have genetic hair loss coupled with hormonal issues or polycystic ovarian syndrome, Dr. Weng says, though it can cause lightheadedness. These drugs usually aren't covered by insurance. Therapy New hair loss therapies for women have come forward in the last decade. Some stimulate hair follicles with targeted laser light; others inject clients with platelet-rich plasma or stems cells to try to get hair to grow. Some of these treatments cost thousands of dollar, and most times aren't covered by insurance. You should get a blood test before trying any of them, Cornman's trichologist, William Gaunitz of Laguna Beach, Calif. says. (Trichologists specialize in treating diseases of the hair and scalp.) If women are deficient in iron or zinc, then trying to activate the building blocks for healthy hair growth can cause the follicles to become overstimulated and even lead to profuse shedding, he says. Nutritional Supplements Gaunitz says poor nutrition is a big factor in the 100,000-plus women he has treated. 'Women are more susceptible to accelerating genetic hair loss, because of fad diets," he says. Vitamin D3 deficiency is by far the largest cause, followed by deficiencies in Ferritin, which stores iron, and then in vitamin B12. Women going through menopause have the toughest hand dealt to them. Estrogen levels drop sharply, which means the body's natural hair protection hormone is close to off duty, Gaunitz explains. They may need to take nutritional supplements for vitamins D3 or B12, he says. One of the biggest misconceptions out there: Biotin supplements will give women beautiful locks. Not true, says Dr. Carolyn Goh, dermatologist and director of the Hair and Scalp Disorders Clinic at UCLA Health. Unless you are deficient in this vitamin, taking supplements won't help. Lifestyle Changes Stress is another contributor to female baldness. Lack of sleep affects the adrenal and thyroid glands, compounding the problem. Gaunitz tells his clients to avoid stress and sleep seven to eight hours a night. To find out the root cause of hair loss, hair loss tests can help. The Mayo Clinic suggests a scalp biopsy in which a doctor collects samples and examines them under a microscope, a light microscopy in which a doctor examines hairs on the head with a special instrument, or a blood test which uncovers medical reasons for hair loss. Women can also do a simple hair pull test at home. Gaunitz tells how to do it. Throughout the head, grip the hairs with your fingers and gently pull them back through the fingers. Do it twice. If you are left with four or more hairs in your hands on the first pull, it signifies 'something to think about;" if you get three or more hairs on the second pull, it's a more pressing problem. Cornman, the former dancer, took supplements to counter her low vitamin D3 level, added natural DHT blockers to the mix, and refreshed her hair care routine. She now has a full head of curly strawberry-blonde hair.

US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies
US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies

Time of India

time20 hours ago

  • Time of India

US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies

Bengaluru: The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a safety program to protect patients from risky drugs, for currently approved CAR-T cell immunotherapies. REMS is required by the FDA to ensure a drug's benefits outweigh its risks by managing serious safety concerns. The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed warnings for cytokine release syndrome and neurological toxicities, and medication guides. The cancer therapies include Bristol-Myers Squibb's Breyanzi and its partnered therapy Abecma with 2seventy bio , Johnson & Johnson's unit Janssen and Legend Biotech's Carvykti, Novartis AG's Kymriah, and Gilead Sciences' unit Kite's Tecartus and Yescarta. Bristol-Myers Squibb and Gilead Sciences did not immediately respond to Reuters' requests for comment. These are gene therapies that are currently approved to treat blood cancers, such as multiple myeloma and certain types of leukemia and lymphoma, the health regulator said. CAR-T treatment generally involves extracting disease-fighting white blood cells known as T-cells from a patient, re-engineering them to attack cancer and infusing them back into the body. In January 2024, the FDA asked several drugmakers to add a serious warning on the label of their cancer therapies that use CAR-T technology after reports of T-cell malignancies and adverse events identified since approval. The FDA earlier said the risk of T-cell malignancies including leukemia and lymphoma applies to all therapies in the class and can lead to hospitalization and death.

Reading food labels isn't enough! THESE everyday ingredients are causing havoc on health; know why
Reading food labels isn't enough! THESE everyday ingredients are causing havoc on health; know why

Time of India

time21 hours ago

  • Time of India

Reading food labels isn't enough! THESE everyday ingredients are causing havoc on health; know why

Many seemingly harmless store-bought foods contain hidden ingredients that pose significant health risks. Food dyes like Red 40 and Yellow 5 are linked to hyperactivity, while titanium dioxide, used to whiten foods, is classified as a potential carcinogen. Other concerning additives include brominated vegetable oil, potassium bromate, and high fructose corn syrup, all associated with various health problems. Store-bought ingredients and foods may look seemingly harmless, however, they are raising new health challenges every day. If you think reading the label alone is going to save you from harmful health hazards, it's time to burst your bubble. From your favorite breakfast cereal to that healthy protein bar you grab, have hidden ingredients that are silently harming your health. Here are some everyday ingredients that can negatively affect your health. Food dyes Food dyes are everywhere. From candies to the flavoured rice you buy. Though these synthetically produced dyes make your food look more colourful and appealing, the cost you pay is beyond imagination. Artificial food dyes, like Red 40 and Yellow 5, may pose significant health risks. These dyes are linked to neurobehavioral issues, particularly in children, with some research indicating increased hyperactivity. Earlier this year, the US Food & Drug Administration (FDA) banned Red No. 3 gives foods and beverages a bright cherry-red color, due to its association with cancer. However, this continues to be used in several countries. Titanium dioxide We all love our food to look good. Well, this appealing nature to certain foods are brought by a chemical called titanium dioxide. It is used to whiten foods like coffee creamers, candies, sunscreen, and toothpaste. However, this chemical is categorized as a Group 2B carcinogen by the FDA . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Neuropatia incomodando à noite? Veja o que muitos idosos estão usando para aliviar os sintomas. A arte do herbalismo Undo The nanoparticles in titanium dioxide may cause inflammation and oxidative stress. Brominated vegetable oils Representative Image Brominated vegetable oil (BVO) is a food additive, an emulsifier used in foods. It is used to stabilize citrus-flavoured drinks. This way it stops flavour oil from separating from the drink. Studies show connections to neurological problems, thyroid dysfunction, and heart and liver damage. Though it is banned in Europe and in the US, it is still used in several countries. Shreyas Iyer and Ibrahim Ali Khan's Nutritionist Nicole Kedia Breaks Down Their Diet SECRETS Potassium bromate Potassium bromate is a flour additive used in making bread. This chemical compound is used to strengthen dough. However, it is classified as a possible human carcinogen by the World Health Organization. This ingredient is banned in Europe, Canada, and other regions. Potassium bromate is a nephrotoxin both in animals and humans. It is also linked to kidney and thyroid tumours in animals. High fructose corn syrup High fructose corn syrup (HFCS) is a sweetener. It is used in sodas and snacks, and is the leading contributor to obesity and diabetes. Studies have found that HFCS intake disrupts the metabolism. As a result, it increases fat storage and insulin resistance. From sugary beverages to processed food, most of them contain this ingredient.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store